Sign in
CompletedNo phase

Post-approval Follow-up Study of the IC-8 Apthera Intraocular Lens (IOL)

Key facts

Who runs it
AcuFocus, Inc.
Where
Bakersfield, Bloomington, Brecksville, Draper, Fort Collins, Greensboro, Houston, Laguna Hills, Los Altos, Los Angeles, Norfolk, Ogden, Omaha, Philadelphia, Poughkeepsie, San Antonio, Sioux Falls, St Louis, Tucson, and Wilkes-Barre, United StatesSee the 20 sites
Trial code
Status
Completed
People taking part
196 people enrolled
Started
12 Jan 2023
Ended
16 Feb 2024
Type of study
Observational
Record updated
2 April 2024

Who can take part

Age
22 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Enrolled in Investigational Device Exemption (IDE) G180075 study and implanted with the IC-8 Apthera intraocular lens (IOL)
  • Able to comprehend and have signed a statement of informed consent
  • Availability, willingness, ability and sufficient cognitive awareness to comply with examination procedures and study visit(s)

Who cannot take part

  • There are no exclusion criteria for this study

Where in United States

  • Empire Eye & Laser CenterBakersfield, United States
  • Chu Vision InstituteBloomington, United States
  • Cleveland Eye ClinicBrecksville, United States
  • Hoopes VisionDraper, United States
  • Eye Center of Northern ColoradoFort Collins, United States
  • Physicians ProtocolGreensboro, United States
  • Baylor College of MedicineHouston, United States
  • Harvard Eye AssociatesLaguna Hills, United States
  • Altos Eye PhysiciansLos Altos, United States
  • Advanced Vision CareLos Angeles, United States
  • Virginia Eye ConsultantsNorfolk, United States
  • Utah Eye CentersOgden, United States
  • Kugler VisionOmaha, United States
  • Philadelphia Eye AssociatesPhiladelphia, United States
  • Alterman, Modi & WolterPoughkeepsie, United States
  • Parkhurst NuVisionSan Antonio, United States
  • Vance Thompson VisionSioux Falls, United States
  • Pepose Vision InstituteSt Louis, United States
  • Fishkind, Bakewell, Maltzman, Hunter & Associates Eye Care & Surgery CenterTucson, United States
  • Bucci Laser VisionWilkes-Barre, United States

About the trial

What the trial wants to find out

The purpose of this study is to evaluate the long-term safety of the IC-8 Apthera intraocular lens (IOL).

The group in the trial

  • IC-8 Apthera intraocular lens (IOL) Group

    Patients previously enrolled in the IC-8 Apthera IOL Investigational Device Exemption (IDE) study (G180075) and implanted with the IC-8 Apthera IOL.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Post-approval Follow-up Study of the IC-8 Apthera IOL
Record updated
2 April 2024